Novartis submits application for marketing approval of Bexsero meningitis B vaccine Novartis submitted its FDA application for Bexsero, a meningitis B vaccine. While 34 countries have already approved it, Bexsero was used in the United States only under a Investigational New Drug designation due to university outbreaks. by Anne Francis
Chatbots Could Be Suffering from Confirmation Bias When Tackling Controversial Issues: John Hopkins Study